A
recent study by Transparency Market Research (TMR) forecasts that the
global hospital infection therapeutics market will grow at a CAGR of
3.1% between 2014 and 2020. TMR, a market intelligence company based
in the United States, in its recently released report states, that
the global hospital infection therapeutics market is anticipated to
reach a market value worth US$3.62 billion by 2020 from US$3.06
billion in 2013. The report titled “Hospital Infection Therapeutics
Market - Global Industry Analysis, Pipeline Analysis, Size, Share,
Growth, Trends and Forecast, 2014 - 2020” is available for sale on
the website.
Browse
the full Hospital Infection Therapeutics Market Report at
http://www.transparencymarketresearch.com/hospital-infection-therapeutics.html
According
to this market research report, a growing geriatric population,
rising demand for better therapeutic drugs, high incidence of
hospital infections, and greater healthcare awareness are a few of
the prominent factors that drive the global hospital infection
therapeutics market. The infections which the patients undergoing
treatments in hospitals contract during their stay in the hospitals
are known as hospital-acquired infections (HAI) or hospital
infections. These infections spread in healthcare settings such as
nursing homes, rehabilitation centers, hospitals, dialysis centers,
and outpatient surgery centers. It has been observed that most cases
of hospital infections originate from the ICUs (Intensive Care Units)
as against other divisions.
The
TMR report segments the global hospital infection therapeutics market
on the basis of drug type, major infections, and geography. On the
basis of drug type, this market is segmented into antifungal drugs,
antibacterial drugs, and antiviral drugs. Based on major infections,
the hospital infection therapeutics market is segmented into
bloodstream infections, gastrointestinal disorders, hospital-acquired
pneumonia (HAP), urinary tract infections, surgical site infections,
and other hospital infections.In 2013, the largest share in the
global hospital infection therapeutics market was held by the segment
for hospital-acquired pneumonia, with a market share more than 20%.
However, the segment for urinary tract infections will grow at a
rapid rate in the forthcoming years.
Geographically,
this research study classifies the global hospital infection
therapeutics market into Asia Pacific, Europe, North America, and
Rest of the World. In revenue terms, North America dominates the
overall hospital infection therapeutics market. The second largest
market after North America is Europe. High demand for advanced drugs,
high incidence of hospital infections, increasing number of
multidrug-resistant microbial pathogens are the key factors that
propel the North America hospital infection therapeutics market. The
other factors driving the North America market are high income levels
and greater healthcare awareness amongst the masses. However, owing
to increasing income levels, rising awareness, and better healthcare
infrastructure, it is the Asia Pacific hospital infection
therapeutics market that will witness highest growth rate in the
years to come.
Browse
the full Press Release Report :
Key
factors that hamper the growth of the overall hospital infection
therapeutics market are greater number of multi-drug resistant
bacterial strains and greater infection control and hospital
surveillance programs in advanced economies leading to lower
incidence of hospital infections.
Some
of the key companies in the global hospital infection therapeutics
market include Sanofi, Pfizer, Inc., Merck & Co., Inc.,
GlaxoSmithKline plc, Bristol-Myers Squibb Company, AstraZeneca plc,
and Actavis plc.
Request
a Brochure of this Report:
http://www.transparencymarketresearch.com/sample/sample.php?flag=s&rep_id=1280
About
Us
Transparency
Market Research (TMR) is a global market intelligence company
providing business information reports and services. The company’s
exclusive blend of quantitative forecasting and trend analysis
provides forward-looking insight for thousands of decision makers.
TMR’s experienced team of analysts, researchers, and consultants
use proprietary data sources and various tools and techniques to
gather and analyze information.
TMR’s
data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and
information. With extensive research and analysis capabilities,
Transparency Market Research employs rigorous primary and secondary
research techniques to develop distinctive data sets and research
material for business reports.
Contact
Mr.
Nachiket
State
Tower,
90
State Street,
Suite
700,
Albany
NY - 12207
United
States
Tel:
+1-518-618-1030
USA
- Canada Toll Free: 866-552-3453
Email:
sales@transparencymarketresearch.com
Website:
http://www.transparencymarketresearch.com
No comments:
Post a Comment